Cluster RCT in Burkina Faso: after 36 months of twice-yearly mass azithromycin vs placebo for children aged 1-59 months, gut macrolide resistance determinants did not differ significantly (fold-change 1.21; 483 samples analysed), nor did non-macrolide resistance.
RCTn = 483 samples
Oldenburg et al. Macrolide and Nonmacrolide Resistance After 36 Months of Mass Azithromycin Distribution in Burkina Faso: A Cluster Randomized Trial